Callan Family Office’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92M Buy
5,739
+121
+2% +$83.7K 0.09% 229
2025
Q4
$3.2M Buy
5,618
+3,078
+121% +$1.79M 0.07% 256
2025
Q3
$1.55M Sell
2,540
-36
-1% -$20.4K 0.05% 307
2025
Q2
$1.29M Buy
2,576
+1,403
+120% +$690K 0.04% 351
2025
Q1
$601K Sell
1,173
-143
-11% -$68.3K 0.05% 291
2024
Q4
$618K Buy
+1,316
New +$662K 0.04% 329

Other funds holding NOC

Callan Family Office's NOC Position: Q1 2026 in Review

Callan Family Office increased its Northrop Grumman (NOC) stake by 2.2% in Q1 2026, buying an estimated $83.7K and bringing the position to 5,739 shares worth $3.92M. The position accounts for 0.09% of the portfolio, ranked #229.

Callan Family Office first reported a position in NOC in Q4 2024 and has held it in 6 quarters since. 1,876 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Callan Family Office held 5,739 shares of Northrop Grumman worth $3.92M as of Q1 2026.
  • Callan Family Office bought 121 Northrop Grumman shares in Q1 2026, an estimated $83.7K.
  • Northrop Grumman made up 0.09% of Callan Family Office's portfolio in Q1 2026, its #229 holding.
  • Callan Family Office first reported a position in Northrop Grumman in Q4 2024 and has held it in 6 quarters since.
  • 1,876 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.